2019-2023年高度致病性禽流感病毒的令人担忧的情况
Zhiwei Zhang1,2, Zhao Lei1
1State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University, Xiamen, Fujian Province, People's Republic of China.
Global medical genetics
|July 1, 2024
概括
高致病性禽流感病毒 (HPAIV) 继续在全球传播,影响家禽和人类健康. 这项研究考察了2019-2023年的HPAIV流通,演变和传播,以告知控制策略.
科学领域:
- 兽医病毒学 兽医病毒学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 禽流感病毒 (AIV) 对鸟类种群,全球禽业和人类健康构成重大威胁.
- 高致病性禽流感病毒 (HPAIV) 的持续传播带来了持续的挑战.
- 近年来,HPAIV活动增加,需要更新理解.
研究的目的:
- 为了阐明2019年至2023年间全球HPAIVs的循环模式.
- 评估HPAIVs正在进行的演变和惊人的传播.
- 讨论AIVs有效的传播和预防策略.
主要方法:
- 对HPAIV爆发的监测数据的审查.
- 对遗传序列的分析,以追踪病毒的进化.
- 传播动态的流行病学评估.
主要成果:
- 记录了2019-2023年HPAIV的全球广泛流通情况.
- 鉴定了循环HPAIV菌株的持续基因演变.
- 突出了关键的传播路线和风险因素.
结论:
- 高PAIV仍然是一个持续的威胁,需要保持警的监测.
- 了解病毒演变对于有效的疾病控制至关重要.
- 综合预防和控制策略对于减轻AIV影响至关重要.
更多相关视频
12:09Avian Influenza Surveillance with FTA Cards: Field Methods, Biosafety, and Transportation Issues Solved
Published on: August 2, 2011
19.3K
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
8.3K
相关概念视频
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Viral Recombination
23.4K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.4K
Vaccinations
44.4K
Overview
44.4K
